Inventor · disambiguated record
Ian Robert Hardcastle
Also filed as: HARDCASTLE IAN · HARDCASTLE IAN R · HARDCASTLE IAN ROBERT
19 granted patents·6 pending applications·235 citations·filing 1993–2024
94Inventor score
Files withASTEX THERAPEUTICS LTD7CANCER REC TECH LTD4BRITISH TECH GROUP3KUDOS PHARM LTD3CANCER RESEARCH TECH LTD2
Top patents by PatentIndex Score
25 records- 0195US10544132B2Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2016·Granted Jan 28, 2020·10 cites·27 claims
- 0294US5604213A17-substituted steroids useful in cancer treatmentBRITISH TECH GROUP·Filed 1994·Granted Feb 18, 1997·113 cites·22 claims
- 0392US10981898B2Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2019·Granted Apr 20, 2021·4 cites·27 claims
- 0492US10526311B2Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2016·Granted Jan 7, 2020·6 cites·25 claims
- 0590US7402607B2DNA-PK inhibitorsKUDOS PHARM LTD·Filed 2005·Granted Jul 22, 2008·16 cites·13 claims
- 0688US10414726B2Therapeutic agentsCANCER RESEARCH TECH LTD·Filed 2017·Granted Sep 17, 2019·6 cites·19 claims
- 0787US9358222B2Therapeutic agentsCANCER REC TECH LTD·Filed 2013·Granted Jun 7, 2016·9 cites·12 claims
- 0885US11261171B1Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2019·Granted Mar 1, 2022·2 cites·24 claims
- 0983US8618158B2Therapeutic agentsGOLDING BERNARD THOMAS·Filed 2009·Granted Dec 31, 2013·10 cites·19 claims
- 1082US8258175B2Isoindolin-1-one derivativesWILLEMS HENDRIKA MARIA GERARDA·Filed 2005·Granted Sep 4, 2012·10 cites·9 claims
- 1182US7674823B2DNA-PK inhibitorsCANCER REC TECH LTD·Filed 2007·Granted Mar 9, 2010·3 cites·7 claims
- 1282US2025092027A1Isoindolinone inhibitors of the mdm2-p53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2024·Application pending·0 cites
- 1377US7696203B2DNA-PK inhibitorsKUDOS PHARM LTD·Filed 2006·Granted Apr 13, 2010·4 cites·9 claims
- 1475US5618807AMethod for preparing 17-substituted steroids useful in cancer treatmentBRITISH TECH GROUP·Filed 1995·Granted Apr 8, 1997·28 cites·9 claims
- 1573US10344017B2Pyrrolcarboxamide derivatives for the inhibition of ERK5CANCER RESEARCH TECH LTD·Filed 2015·Granted Jul 9, 2019·2 cites·20 claims
- 1671US7226918B2DNA-PK inhibitorsCANCER REC TECH LTD·Filed 2002·Granted Jun 5, 2007·4 cites·9 claims
- 1770US12071429B2Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2021·Granted Aug 27, 2024·0 cites·27 claims
- 1870US7105518B2Thiopyrane-4-ones as DNA protein kinase inhibitorsCANCER REC TECH LTD·Filed 2002·Granted Sep 12, 2006·5 cites·8 claims
- 1967US2022106287A1Isoindolinone inhibitors of the mdm2-p53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 2058US7732483B2DNA-PK inhibitorsKUDOS PHARM LTD·Filed 2008·Granted Jun 8, 2010·0 cites·11 claims
- 2152US2011130386A1Dna-pk inhibitorsFRIGERIO MARK·Filed 2009·Application pending·0 cites
- 2252US2016355478A1Therapeutic agentsCANCER RES TECH LTD·Filed 2016·Application pending·0 cites
- 2344US2009326223A1Synthesis of 2-amino-substituted 4-oxo-4h-chromen-8.yl-trifluoro-methanesulfonic acid estersGRIFFIN ROGER JOHN·Filed 2007·Application pending·0 cites
- 2436US2004110775A1Cyclin dependent kinase inhibiting purine derivativesFiled 2002·Application pending·0 cites
- 2533US5589500ASubstituted 1,1,2-triphenylbutenes and their use in the treatment of cancerBRITISH TECH GROUP·Filed 1993·Granted Dec 31, 1996·3 cites·13 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →